术后放疗在头颈部腺样囊性癌手术切除患者中的作用
该回顾性研究分析了2005至2019年间187例接受手术切除的非转移性头颈部腺样囊性癌患者,中位随访84.7个月,5年局部区域无失败生存率、无进展生存率和总生存率分别为70.0%、52.6%和86.4%。术后放疗可显著降低局部失败率(16.9% vs 31.0%,P=0.021),尤其在高危患者中可预防不良生存。
要点
- 术后放疗组局部失败率16.9%,未放疗组31.0%(P=0.021)。
- 切缘阳性、T2-4期及小唾液腺肿瘤患者术后放疗后局部失败显著减少且总生存率相似。
- RPA模型根据T分期、部位和性别等将患者分为不同预后组。
核心结论
- 术后放疗可预防头颈部腺样囊性癌高危患者的不良生存,同时显著减少局部失败。
研究设计与样本
- 回顾性分析2005至2019年间187例接受手术切除的非转移性头颈部腺样囊性癌患者。
- 研究终点为局部区域无失败生存率、无进展生存率和总生存率,并进行亚组分析和递归 partitioning 分析。
主要发现
- 中位随访84.7个月,5年局部区域无失败生存率、无进展生存率和总生存率分别为70.0%、52.6%和86.4%。
- 发生局部失败的患者生存期显著短于未发生局部失败者(5年总生存率:88.1% vs 80.5%,P=0.001)。
- 术后放疗组局部失败率显著低于未放疗组(16.9% vs 31.0%,P=0.021),尽管术后放疗组不良因素频率较高。
- 切缘阳性、T2-4期及小唾液腺肿瘤患者术后放疗后局部失败显著减少且总生存率相似。
- 无进展生存率的RPA模型根据T分期、部位和性别三个预后因素将患者分为四组;局部区域无失败生存率和总生存率的RPA模型分别基于T分期和切缘、T分期和3级两个因素分为三组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although postoperative radiotherapy (PORT) is demonstrably effective in local control of head and neck adenoid cystic carcinoma (HNACC), its application is controversial and the subset of patients who would benefit most from PORT is unknown. Herein, we analyzed the data of HNACC patients to clarify the role of PORT. METHODS: We retrospectively reviewed 187 patients with nonmetastatic HNACC who underwent surgical resection between 2005 and 2019. The study endpoints were locoregional failure-free survival (LRFFS), progression-free survival (PFS), and overall survival (OS). Subgroup analysis and recursive partitioning analysis (RPA) were performed to identify patients most likely to benefit from PORT. RESULTS: With a median follow-up of 84.7 months, the 5-year LRFFS, PFS, and OS were 70.0%, 52.6%, and 86.4%, respectively. Survival was significantly shorter in patients who experienced local failure than in those who did not (5-year OS: 88.1% vs. 80.5%, P = 0.001). The local failure rate was significantly lower in patients who underwent PORT (16.9% vs. 31.0%, P = 0.021), despite the high frequency of adverse factors. Especially, significant decreases in local failure and similar OS rates could be obtained after PORT among patients with positive margins, T2-4 stage disease, and minor salivary gland tumors. The RPA model for PFS categorized patients into four groups according to three prognostic factors (T-stage, location, and sex). The RPA model for LRFFS and OS suggested three groups based on two factors (T-stage, margin for LRFFS; T-stage, grade 3 for OS). CONCLUSION: PORT could prevent dismal survival, while significantly reducing local failures in high-risk HNACC patients.
引用
- Choi SH, Yang AJ, Yoon SO, et al. Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck. Radiat Oncol. 2022. PMID: 36456955. doi:10.1186/s13014-022-02165-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。